R. Fedriga et al., Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine, NEOPLASIA, 3(5), 2001, pp. 446-450
Early diagnosis is one of the most determining factors for patient survival
. The detection of telomerase activity is a potentially promising tool in t
he diagnosis of bladder and other types of cancer due to the high expressio
n of this enzyme in tumor cells. We carried out a quantitative evaluation o
f telomerase activity in urine samples in an attempt to determine a cut-off
capable of identifying cancer patients. Telomerase activity was quantified
by fluorescence TRAP assay in urine from 50 healthy volunteers and in urin
e and bioptic tumor samples from 56 previously untreated bladder cancer pat
ients and expressed in arbitrary enzymatic units (AEU). Telomerase activity
in urine ranged from 0 to 106 AEU (median 0) in healthy donors and from 0
to 282 AEU (median 87) in patients with cancer. A telomerase expression hig
her than the cut off value determined by receiver operating characteristic
(ROC) analysis was observed in 78% of cases, regardless of tumor grade and
in 71% (15/21) of cases of nonassessable or negative cytology. The quantita
tive analysis of telomerase activity in urine enabled us to define cut-off
values characterized by different sensitivity and specificity. Cytologic an
d telomerase determination, used sequentially, enabled us to detect about 9
0% of tumors.